Perpetua Resources Secures 29 Billion US Loan for Idaho Critical Minerals Project Charter Communications Revises Liberty Broadband Buyout Terms in New Acquisition Agreement Stocks Edge Higher on Solid Fundamentals Market Rally Continues UK Exports to US Plunge 25 After Trumps Liberation Day TariffsTrade Deficit Emerges OpenAI IPO Filing Possible This Week Sources Say Indias SEBI Proposes EquityLike Norms for Debt Market Plans Tokenised Bond Pilot VTVT Q1 2026 Earnings Massive EPS Beat Driven by OneTime Items Stock Declines PRME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress JNJ Q1 2026 Earnings Narrow EPS Beat Signals Operational Resilience Amid Mixed Market Sentiment Lucid Group LCID Q1 2026 Earnings Wider Loss Than Expected as Production Ramp Challenges Persist GEG Q1 2026 Earnings Significant Earnings Miss Despite No Revenue Impact The Marzetti Company MZTI Q1 2026 Earnings EPS Falls Short of Expectations Stock Gains Modestly Aris Mining ARIS Faces Resistance at 178 Support Tested at 161 Algonquin Power Utilities Preferred Shares AQNB Edge Higher Amidst Steady BondLike Trading United Rentals URI Rallies 26 Key Levels and Sector Momentum in Focus Cartesian Therapeutics RNAC Slumps 77 as Selling Pressure Intensifies LaFayette Acquisition Corp Rights LAFAR Holds Steady at 011 Support and Resistance in Focus Gen Zs Bargain Hunt Fuels Growth for Discount Retailers Walmart and Ross FHN Q1 2026 Earnings EPS Beats Estimates by 62 Stock Edges Lower on Caution Gemini Space Station Inc GEMI Slips 246 Evaluating Key Levels Near Support VRCA Q1 2026 Earnings EPS Misses Estimates as Commercialization Costs Weigh on Results ABBV Q1 2026 Earnings EPS Edges Past Estimates as Stock Slips PostRelease Arteris Inc AIP Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Investor Sentiment ILPT Q1 2026 Earnings Earnings Beat Driven by Cost Management Shares Edge Lower TTEK Q1 2026 Earnings EPS Beats Estimates by 417 Stock Rises Slightly JBI Q1 2026 Earnings EPS Misses Estimates Amid Revenue Disclosure Absence IMVT Q1 2026 Earnings EPS Misses Estimates as Clinical Investment Intensifies